marijuana stocks to buy

interesting - search results

If you're not happy with the results, please do another search

0 1441
Marijuana Stocks to Buy

This week has seen some wild swings up and down for a bunch of familiar marijuana stocks and some that may not be so familiar. It’s been a week of accumulation for some, resurrection for others and a coming out party for one. All and all investors finding the right stocks to court seem to be content with their choices for now. Lets take a snapshot of the sector in : The Week in Review….

OXIS International, Inc.(OTCMKTS:OXIS)

This week Oxis has essentially been going sideways with some nice dips and bounces of the 50 day moving average. The volume has been very good and actually getting stronger which is important for traders and investors. The swings have been between 20-30%, but what is very telling about OXIS right now is that it is mirroring the movement it had from January to February while it was in the 2 cent range for almost 2 months before it made it’s move into the 4’s & 5’s. Biotech stocks are very much in demand these days on the big boards and the OTC, LBIO which we see as Oxis’ cousin is trading at around $12 on the Nasdaq, if you held that Tony Cataldo stock when it was .02, reversed (in Order to bring in serious funding) and then up-listed then you are a seriously happy camper. So far MGMT has kept their word while increasing shareholder value. Full Disclosure Oxis is my biggest position, and i’m comfortable holding a core and trading a core on spikes. I anticipate some new news to take this to the next level. The week has been a good one with the buy/sell ratio near 70/30% in favor of buying. As for todays news about the trading resuming on the EuroNext its best summed up like this… MM’s will not be able to mess with the share price by shorting it in the OTC & Covering on the EuroNext. As I’m writing this OXIS has dipped and I just added.

MassRoots Inc (OTCMKTS:MSRT)

Thursday Mass Roots which is a very popular App in the Cannabis space went public in my eyes pretty quietly. It is a company aimed at bringing all things cannabis into a social network setting. I saw one tweet describing it as “Facebook on weed,” well at $1.07 it sounds like a bargain if they can capture 1% of FB’s audience. IPO’s are always tricky especially when it comes to technology that’s not Apple or Google. Take KING or ZNGA for example, they have gaming apps that essentially print $ every single day, yet the market does not like them. KING’s IPO last year opened at $22 and it now trades just under $17, but has gone as low as $10, ZNGA fared far worse (but they don’t have Candy Crush). MSRT should be interesting, other MMJ IPO’s in the last year include TWEED & Bedrocan all down off their IPO price, but I will reach out to the CEO next week to see what’s truly up with Mass Roots.



Has been in the last week wildly volatile, and while we like it we were able to stay objective on April 1st when we called the top and told people “taking profit will be the smartest thing you do today on $THCZ.” SInce then it has plunged from .30 to .07, bounced back to .19+ and dipped back down to .15. The last week has been a traders dream where people are making money flipping it or even gambling with their profits. THCZ’s biggest issue is that they still have a Skull & Crossbones on This symbol is obviously meant to scare people off or at the very least tell investors that there is a heightened level of risk associated with the stock. As far as the week goes all you have to do is look at the chart, its a proverbial roller coaster.


What a week it has been for PZOO as the low of the week was .0049 and as of right now the price is .01 and hit .011 yesterday when healthy profit taking took place to cool down the RSI and create a dip to .008 that was bought back by the same people holding a core and trading spikes. This Hold a core trade a core strategy is essential to PPS growth as it creates steady layers of new investors coming in. I always advise people to sell a portion of their holdings on these 30% spikes. Obviously you can ride it out, but this is a way to protect your sanity in the OTC as well as your investment. So what has changed with PZOO? Well they are partnering with a prolific lab known as Steep Hill, who is very well known in the Cannabis space and they work with many well known cannabis providers as well as have clients that generate very healthy revenues. As for PZOO, we would like to welcome them to officially in an effort to create organic awareness for the company & transparency for investors.

Blue Line Protection Group Inc (OTCBB:BLPG)

Blue Line Protection group is still what we consider here at an under the radar gem in the cannabis sector. Investors should note that they are far from just a Marijuana Security firm and offer some of the most recognized marijuana producers in the nation a cornucopia of services from banking options to vault storage of cannabis and vast sums of cash. Media wise they have been covered by CNN, CNBC, MSNBC, Fox Business and so on. Our feeling is that once people see that they are revenue producing juggernauts with a massive expansion footprint happening now the PPS will reflect their actual value. As such it is our belief that BLPG is still undervalued! With that being said the stock is trading nicely from an accumulation standpoint and is still 20% above where we started covering it (.165).

In Closing:

As for the Marijuana Sector in general there have been some companies that have come onto the radars of marijuana investors and provided great trades that we have noticed. These are companies OSLH (OSL Holdings Inc), LIBE (Liberated Energy), & PMCB (Pharmacyte Biotech). OSLH is interesting as they are up about 500% since announcing that they are potentially partnering with Cheryl Shuman one of the most visible females in the entire cannabis space. As we are now in April it’s important for traders to follow the volume, keep their ear to the ground and be on the look out sector catalysts like this one we found about the DEA tripling production of Medical Marijuana and what it can mean to MMJ being a schedule 1 drug. All in all it has been a good week for those people that have a strategy for all the Marijuana Stocks they choose to buy and sell. Cheers-

0 397

Note to Republicans: Want the Millennial Vote? Support Weed

Cannabis may in fact sway the 2016 Presidential election. In a recent segment of commentary for Roll Call, political consultant Steven Moore attracts eyes to an interesting phenomenon, which displays the millennial generation is more likely to cast a ballot in an election if the concern of cannabis is at risk. He goes on to say that if a Republican expects to get their hands on the keys to the White House in 2016, it will be important to get the nation’s youth on their team, and the best plan for succeeding with this goal may be to take a pro-cannabis platform.

However the constitutional amendment to legalize medicinal cannabis in Florida failed in last November’s election, Moore gives details that Republicans should keep a close eye to the youthful enthusiasm built up by the issue. While voter turnout across the U.S. was low, Florida experienced a 10%  gain from 2010. Also, millennia’s took over a larger share of the electorate by 6%, while seniors fell off by 10 points.

To prove even more that cannabis is a popular conern among millennial voters, look to the passing of Colorado’s Amendment 64 in 2012. During the election, the state witnessed  11% more voters under the age of 29 than in 2008. And in Washington state, there was a 4% gain in voters under the age of 30.

If medicinal cannabis makes it to the Florida ballot in 2016, which is expected, Moore proposes it will raise “marijuana law reform from a state issue to a national issue” since “most strategists see few options for a Republican in the White House if Democrats win Florida.”

Obama won Florida in 2008 with 61% of the millennial vote; 66% in 2012. However, Republicans McCain and Romney were defeated in the election by a few points. “With the margin so slim, and the trend over time going the wrong way, Republicans don’t necessarily need to win millennials, they just need to not lose them so badly,” stated by Moore.

Yet it might prove challenging for Republicans to gain the attention of millennials while protecting their base, Moore believes the problem might not be as hard to conquer as it has been in the past. “An October ’14 Gallup poll shows that nationally, one in three conservatives and four in ten Republicans favor making marijuana completely legal,” he stated, adding that “Republican support for marijuana legalization has nearly doubled since 2006.”

It is true that cannabis legalization is widely viewed as a state issue, which Moore argues would be precise if it were not “for the disproportionate influence the state of Florida has on presidential elections.”

It is for this reason that Moore throws caution to the wind with Republicans not to speak ill of cannabis reform. “Prohibitionist rhetoric may drive away the unique intersection of millennial and Republican voters likely to decide next year’s razor-thin presidential margins in Florida. Alternatively, addressing the issue in a thoughtful and strategic manner may serve to bring these voters into the GOP tent, and help assure a Republican in the White House.”

0 667

Chaos D.C.: Marijuana Becomes Legal Next Week Without Regulations

The District of Columbia’s recently passed voter Initiative 71, which legalized the growing, possession and use of cannabis in Washington DC, has nearly survived its one month congressional review and the recent law is set to take action within next week. Shortly, people 21 and older will be able to have up to two ounces of pot in there possession, cultivate six plants in their backyard, and give pot away to friends without risking the consequence of a law enforcement raid. Though, an article published Monday in The Washington Post stated “chaos” could burst in the beginning of legalizing marijuana because the federal government has halted the D.C. Council from experimenting with a regulatory system to structure the market from coming unhinged.

The issue, at least understood in the minds of some District lawmakers, is that while marijuana has reached legal stature in the backyard of the White House, there is sure  to be an rise in borderline black market dealings because the law does not come linked with regulations to accommodate consumers in the legal investment of marijuana. “Where can it be bought? Sold? Eaten? Smoked? We’re not going to have answers to any of that, and that makes me very concerned,” D.C. Council member David Grosso stated to the Post. “And as the consequences play out in the nation’s capital, he said, it could set back the entire movement: “Let’s be responsible about how we do this so we don’t have a negative image coming out.”

Unlike Colorado, marijuana users in the D.C. will not have the advantage of buying pot at a local marijuana shop. However, reports reveal that plans have already begun for marijuana clubs, which will give members with recreational cannabis for a yearly fee, although there are rumors that catered marijuana cuisine, paid for through donations, shall be provided throughout the city. Tiffany Bowden with Comfy-Tree, one of the organizers of a Marijuana Expo set to get initiated later this month on Capitol Hill, stated these types of businesses are only the starting point for the cannabis market in Washington D.C. “The District will be unique because you can’t technically sell cannabis directly,” she stated. “All that means is the traditional dispensary model as we know it will not happen. But that doesn’t mean the cannabis industry is going to be asleep. It’s actually going to be thriving in Washington.”

This off beat direction from the traditional model, like the system developed in Colorado, is what some assume will lead to Chaos inour nations capital – all due to Congress’ eagerness to interfere with the District’s cannabis laws. The concern is that industrious minds have read between the lines of the initiative and are getting ready to get a portion of the clearly  non-existent market share when the law comes to pass on February 26. According to the Post, D.C. Attorney General Karl Racine is showing law enforcement how to go about  the new law, but there are still so many unanswered questions, especially in connection to marijuana consumption and the definition of “remuneration.” In fact, during a recent sit down with Mayor Muriel Bowser, Council member Grosso asked her what would happen to a person if apprehended from using pot outside of a “cannabis club,” and she was unable to give clear answer.

Interestingly, Initiative 71 was picked up to influence growing marijuana from home, and was in no way intended to be a stepping-stone to a retail marijuana market. However, while the capitals lawmakers are hurting in their attempts to establish a taxed and regulated cannabis market for at least the next year, it looks like entrepreneurs are gearing up to push the envelope of the law in order to capitalize on marijuana once it is officially legal… but will this prove toe chaos? Obstacles, possibly, but surely nothing beyond a reasonable answer.

0 854

4 ways cannabis is good for your brain — and may save your life

Current investigations are showing that marijuana extracts help to protect and benefit the human brain. Here are some ways scientists are revealing that marijuana actually helps to keep your brain safe from sickness, dementia and in some cases death

#4 – Cannabis promotes new brain cell growth

Government scare campaigns more times then not claim that cannabis kills brain cells, but now we are discovering the truth. Those studies in the ’70s were not given credit, by the use of strapping a gas mask on the mouth of a monkey and delivering hundreds of joints worth of marijuana smoke. The monkeys experienced lack of oxygen, and that was the cause of why their brain cells died.

Modern investigations are now showing the opposite. The main compounds in cannabis spur the development of new brain cells! Back in 2005, Dr. Xia Zhang at the University of Saskatchewan presented that cannabinoids cause “neurogenesis” – which is defined as they aid new braincell growth

“Most ‘drugs of abuse’ suppress neurogenesis,” stated Dr. Zhang. “Only marijuana promotes neurogenesis.”

Scientists in Brazil found more on this research, showing examples, in 2013 that CBD, another compound in cannabis, also causes new braincells to grow, Researchers in Italy then had the same conclusion with CBC, another “cannabinoid” found in marijuana resin.

Now there is no question that cannabinoids cause new brain cells to sprout up in the hippocampus. This helps explain prior investigations displaying that cannabinoids effectively help mood disorders such as depression, anxiety and stress – they are all in connection to a lack of adult neurogenesis.

#3 – Cannabis prevents Alzheimer’s

Close to 5 millions Americans are diagnosed  with Alzheimer’s. There could be light at the end of the tunnel. Modern analysis reveals that utilizing marijuana helps prevent the cause of Alzheimer’s and dementia by cleaning away beta-amyloid “brain plaque.” A  study conducted about cannabis and Alzheimer’s was headed by Dr. Chuanhai Cao, PhD, a neuroscientist at the Byrd Alzheimer’s Institute. “THC is known to be a potent antioxidant with neuroprotective properties,” said Cao, explaining that THC “directly affects Alzheimer’s pathology by decreasing amyloid beta levels, inhibiting its aggregation, and enhancing mitochondrial function.”

This proved earlier research, for example research from 2008 which discovered that THC “simultaneously treated both the symptoms and progression of Alzheimer’s disease.” This study relate was, “compared to currently approved drugs prescribed for the treatment of Alzheimer’s disease, THC is considerably superior.”

These investigations used very low levels of THC to find these answers – the levels you might find in a marijuana user that doesn’t smoke often. So where are the headlines displaying “Smoking Cannabis Prevents Alzheimer’s”?

#2 – Cannabis prevents brain damage after strokes and trauma

Multiple recent investigations have discovered that cannabinoids defend the brain from permanent damage after severe medical conditions. Research found in 2012 and 2013 showed that a low dose of THC give protection to mice’s brains from suffering by carbon monoxide and head injuries. Researchers show that THC “protected brain cells and preserved cognitive function over time” and influenced the idea that it could be used preventively, for ongoing defense.

Research in 2014 found that people with low amounts of THC in their body were near 80% less likely to die from major head trauma than those without. This last study is really quite phenomenal and should have been headline in the news. Scientist analyzed blood samples from hundreds of people who had suffered head trauma, and discovered that people with small amounts of cannabinoids in their system were 80% less likely to be killed from head injuries.

This means that in a group of occasional marijuana users and a group of abstainers who have similar brain injuries, the marijuana users will have only 2 deaths for every 10 suffered by the whodo not use marijuana. There are 52,000 fatalities every year from traumatic head injury in America. This investigation showed that if every adult American had a pull of marijuana once a week, 20% of those deaths would not occur  – that’s close to 41,600 people that could be saved, every year.  Still this hasn’t made front page news?

#1 – Cannabis extracts treat brain cancer

One interesting use of cannabinoids is in the aid of cancer treatment. Repeated laboratory and animal research have discovered that cannabinoids eliminate cancer cells and shrink the size of tumors, while aiding to defend normal cells. New information involves a 2012 study displaying that CBD blocked metastasis in aggressive forms of cancer,  a 2013 investigation showing that a mix of six cannabinoids eliminated leukemia cell, and a 2014 study revealing that THC and CBD could be mixed with traditional chemotherapy to produce “dramatic reductions” in brain tumour size.

Using marijuana extracts for brain cancer is nothing that hasn’t been known to the medical world. Research in 1998, found that THC “induces apoptosis [cell death] in C6 glioma cells” – an aggressive type of brain cancer. A 2009 study dave details stating that THC acted “to kill cancer cells, while it does not affect normal cells” in the brain. The medical advantages of cannabis and cannabinoids are infinite, and we are in a day and age where everyone is allowed full access to this wonderful healing plant. You never know? One day maybe we will even get to use outdoor-grown cannabis to develop vast quantities of pure, cost efficient cannabinoids for the millions of people across the nation who need them.

0 601

Medbox’s Largest Shareholder Comments on Recent Events and the Company’s Outlook for 2015

LOS ANGELES, CA–(Marketwired – Dec 30, 2014) – P. Vincent Mehdizadeh — Founder and Majority Shareholder of Medbox, Inc. (OTCQB: MDBX) issued a letter to fellow shareholders today regarding his vision for the future of the company and insight into recent developments affecting the company.

The letter stated:

“Dear Medbox Shareholders:

It has truly been an interesting journey during the last 2 years. When I commenced operations of the private company in 2010 that later became Medbox, I never anticipated that the company would be as noteworthy and relevant as we are today. The company has a rare blend of consulting and patented technology that gives entrepreneurs a jumpstart on realizing their dreams of operating a business in a newly emerging industry. I have thoroughly enjoyed watching our client’s dreams be realized, along with our shareholders that have watched our company grow and prosper over these years.

Medbox rocketed to stardom and notoriety amidst a positive outlook for the marijuana industry in November of 2012 based on favorable election results and highlighted by several media sources, including the Wall Street Journal, which ushered in what many have called the ‘Green Rush.’ In the days that followed, the company’s stock price saw unprecedented increases that was said to have resulted from investors looking to participate in ‘The Next Great American Industry.’ Up until 3 months ago, I was involved in almost every decision the company made, and my decision at that time was to caution investors about investing in any company in the marijuana industry because of the inherent risks. We also publicly cautioned investors to temper their expectations about our stock and to make informed investment decisions. The company fielded criticism in doing so, but we felt that separating ourselves from other public company industry participants in our sector and focusing on protecting investors as best we could was a beneficial direction for the company. In my opinion, one of the keys to Medbox’s success has been superior corporate messaging and timely dissemination of information to our shareholders.

Since that point in time a little over two years ago, I have made it my mission to take the company from being a non-reporting pinksheet to being a fully reporting SEC Filer. I took it upon myself to set these goals and achieve them for the benefit of the company and its shareholders. We did this to have an increased level of transparency so that investors can think of Medbox as the public company standard for respectability and reliability in the newly emerging marijuana industry that was taking shape. As a result, we engaged a Public Company Accounting and Oversight Board (PCAOB) registered auditor, Q Accountancy Corporation, and also hired a full-time Chief Financial Officer, Thomas Iwanski, a CPA with excellent references and extensive public company experience.

Since the company engaged Mr. Iwanski and Q Accountancy Corporation, I also recruited a star-studded board and together we appointed Guy Marsala to lead the company as the Chief Executive Officer. As it was explained to me, in situations where a new CEO is brought on, they typically look to appoint their own Chief Financial Officer. Thus, when Mr. Marsala decided to replace Mr. Iwanski as CFO, I did not give it a second thought, although I was sad to see him go since his experience with public company oversight was superb.

Today, the company’s current management issued a statement regarding the company’s financials. Prior management, including Mr. Iwanski and the company’s current auditor, both disagree with current management’s position on the matter. Both the current auditor and prior CFO have made their opinions known to current management, to no avail. Both have stated that they had support for recognizing revenue in the periods in which they were recognized. However, the company’s current CFO has a difference of opinion on that aspect and believes that the revenue in question should be recognized in later periods, which has now resulted in a proposed restatement set to occur. This fact along with the fact that the revenue items in dispute amount to less than 10% of the total revenue booked for 2013, was not accurately discussed in the disclosure released this morning. 

As stated previously in this letter, corporate messaging and communication to shareholders is one of the many aspects that made Medbox a great company. I now feel the company is not doing enough to accurately disclose matters in a manner that is easy to understand and digest by the public. Stating that the current CFO has a difference of opinion with the prior CFO and current auditor would have gone a long way to explaining the situation properly. Instead, we have the inaccurate and incomplete disclosure that was released today that leaves the public with more questions than giving them the answers they need to understand the situation.

As we were on a path to transition to NASDAQ and had filed an application to be listed on that exchange, I felt that since I had a checkered past that was disclosed in company filings it would tarnish the Medbox brand if I stayed involved in any capacity other than as a consultant to the company. Although these offenses were non-violent, non-securities related offenses, all of which resulted in probation and all occurring prior to Medbox, I still felt that the company would always be a target of ‘short and distort’ campaigns by financial bloggers if I remained an Officer or Director. To that end, I recently gave full control to the board and current management to steer the ship and navigate the company properly. Recent events have caused me to call into question whether current management and the board of directors has enough industry experience to properly run this company. It is for this reason that I will be adding industry-experienced members to the board to work with the current board members to more effectively operate the company. I will also be taking a more active role with the company again to ensure our short-term and long-term goals can be achieved.

I believe that a founder’s passion separates a typical company from a company that achieves the utmost success. The company needs my help now more than ever, and I intend to fill that need to the best of my ability going forward. I look forward to a strong and prosperous future for Medbox.


P. Vincent Mehdizadeh”

About P. Vincent Mehdizadeh, Founder and Majority Shareholder at Medbox, Inc.
P. Vincent Mehdizadeh founded Medbox’s main subsidiary, Medicine Dispensing Systems, in February 2008. He commenced operations for that company in 2010, and in December of 2011 sold that company to what became Medbox, Inc. Mr. Mehdizadeh served as senior consultant from December 2012 until May 10, 2013 for Medbox, Inc. and then transitioned to Chief Operations Officer and Board Chairman for Medbox, Inc. through May of 2014. Mr. Mehdizadeh was responsible for creating the 2 main patents behind the company’s technology, helping to assemble the talented management team at Medbox, and also developing the concept behind the business models driving revenue for the company.

About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Headquartered in Los Angeles, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers their patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (, the company offers an industry award winning medical vaporizer product. Medbox, through its newly established subsidiaries, is in development of the following ancillary services catered to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol research and development, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and alternative medicine dispensary management services.

Media Inquiries:
The Innovation Agency
Email Contact

0 555

SF’s Latest Innovation: A Weed of the Month Club

There has been a lot of controversy lately over people sending pot through the mail, which is a violation of federal law. This, of course, has prevented exceptionally interesting concepts like “Weed of the Month” clubs from realizing their full potential. However, one San Francisco-based business has found a solution to providing a monthly marijuana subscription box service by simply having its cannabis selections hand-delivered to the doors of stoners all across the city.

The company is called Marvina, which is a cannabis club that essentially provides patients holding a medical marijuana recommendation with a strain selection of the month. Just think Birchbox meets FTD flower delivery, and you will have a relatively decent grasp of what this company is attempting to accomplish.

For the full article click here.

0 349

Totally Hemp Crazy Inc. (THCZ) Preparing for Initial Product Run

THCZ to Produce Proprietary Hemp Beverage Line

DALLAS, Dec. 10, 2014 /PRNewswire/ — Totally Hemp Crazy Inc. (THCZ) today has announced that the packaging cans for the new product lines will be ready for final approval this month and then will go into production. The company expects that the cans will be produced and be ready to be shipped to the bottling company by January. The formulations for the beverages were finalized in November and their ingredients along with the proper bar codes were added to the cans’ final designs. The first products to be produced will be the Rocky Mountain High Hemp Iced Tea™, Rocky Mountain High Hemp Lemonade™ and Rocky Mountain High Hemp Energy Drink™. The second wave of hemp infused products to be launched into the marketplace will feature wine based alcoholic beverages (12.5% alcohol) in a 375ml PET flask. The target date for this launch is mid-spring 2015.

Rhino Marketing has completed their first phase of the initial rollout and has specified the initial retail target markets as Houston, Dallas, Austin and San Antonio.  Upon completion of the pilot markets the retail rollout will go nationwide.  A new and improved commerce version of the THCZ website designed by Rhino Marketing is almost complete and will be uploaded this month.  “We are really excited about how this product has progressed and we’re excited to be part of this great drink,” says Thomas Hensey, Rhino Marketing.

“We have raised capital from private placement funding and we are actively involved in negotiations with several other groups so we can produce a complete line of hemp based products that will in total be in excess of a dozen sku’s,” states Founder Jerry Grisaffi. “Several of the interested parties have some very interesting product ideas that will make 2015 a very exciting year for THCZ.  We will share these ideas with the investors upon the completion of the finance negotiations.  We do suggest that investors check the THCZ website on a regular basis as updates from this point on forward will be occurring on a regular basis.”  

Visit us at:

About Totally Hemp Crazy Inc.:

Our mission is to be the first total Hemp beverage company.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

To view the original version on PR Newswire, visit:

0 1071

By Michael Berger

Players Network Inc. (PNTV: OTCQB), is a diversified holding company that is focused on two primary industries, media and medical marijuana. PNTV offers investors the opportunity to invest in a diversified cannabis company that is levered to the legal Nevada marijuana market. PNTV is a one of the only fully reporting companies that has received a license to cultivate and process cannabis. This fact gives us a sense of confidence that PNTV is one of the more legitimate OTC traded marijuana stocks.

Entrance into the marijuana space

In late July, PNTV formed Green Leaf Farms Holdings, Inc. The company used Green Leaf to enter the legal medical marijuana industry and apply for a medical marijuana dispensary in Nevada. A few months later, Green Leaf’s application was approved by the state of Nevada for an edible extraction facility. The facility will be located on a 3.2 acre piece of property purchased by Green Leaf. The land which they purchased is able to support a 70,000 square foot facility which will easily be able to satisfy demand. PNTV owns 80% of Green Leaf Farms Holdings with the remaining 20 percent held by key advisors and experts.

The company is working diligently to hopefully commence operations by mid-2015. These operations will provide PNTV with a source of revenue that will enable the company to continue to grow and invest in profitable business ventures. The company believes that the facility can generate $12 to $14 million in annual revenue in its first year of operation. They expect total revenue generated by the facility to increase year over year as demand grows.

Unique business model can create synergies for their two business units

PNTV is also actively involved in the media industry through their proprietary channels. This offers the company another source of revenue, and free exposure for their marijuana business. The company will use, one of their proprietary channels to increase exposure for Green Leaf. This channel also generates revenues through advertising, cross selling with other companies and premium membership subscriptions.

The company has a unique advantage that makes them an interesting play in the cannabis space. PNTV is able to utilize their two businesses units to create synergies for each other and increase total revenues. These revenues will lead to higher margins, which will improve the company’s bottom line if they are able to execute on their business plan.

Strong management team

PNTV has been around since the early 1990s and they have created many strategic relationships that strengthen the company’s footprint. The company’s CEO and founder, Mark Bradley founded Players Network in 1993 and has served as CEO since the company’s inception. Bradley has been a producer/director at United Artists, and was studio manager and postproduction supervisor with United Cable Television in Los Angeles, engaged in the production, packaging and syndication of television and film productions for such media venues as HBO, Nickelodeon and MTV.

The company’s Chief Creative Officer, Michael Berk, is a prolific writer, producer and director with over three hundred hours of television programming to his credit. Berk created and Executive produced “Baywatch,” the most popular series in television history, and is currently producing a large-budget “Baywatch” feature film for Paramount.

Leslie Thomas is the marketing and operations manager for PNTV. Thomas works directly with major media outlets, including: Comcast Communications, DirecTV, AT&T, Verizon, and TivoCast, as well as multiple broadband sites.

The marketing and licensing advisor, John Raczka, has a proven track record of success in driving revenue growth in the linear, interactive and gaming entertainment sectors worldwide.

Edward Sullivan serves as the company’s media, branding, and marketing advisor. Sullivan has overseen the brand & marketing efforts for over 50 launches and re-launches of major media companies including: CBS, ABC, FOX, Discovery Networks, Turner Broadcasting, HBO and Disney cable networks.

Doug Miller serves on the board of PNTV and brings over thirty years of hands-on operating experience to the Players Network Board. Focusing on high growth start-up and turnaround companies, Mr. Miller participated in leading four companies to IPO´s. Mr. Miller holds a B.A. from the University of Nebraska and an MBA from Stanford University.


PNTV’s entrance into the medical marijuana market offers a lot of upside to current estimates, however the stock has not reacted favorably to this. PNTV is down over 10% since early November even though the story has improved. Technical420 thinks that the company has the potential to be player in the cannabis industry due to their unique business model and the synergies that can be created between Weed TV and Green Leaf Farms Holdings. However, the current trading pattern of PNTV keeps Technical420 on the sidelines until an upward price trend is formed, or until positive guidance is released regarding their Nevada operations.

1 452

Owning a Vending Machine Now One of the Most Popular New Business Ventures

Entrepreneurs have discovered the low cost of entry, ease of management, and high potential ROI

CORONA, Calif., Nov. 26, 2014 /PRNewswire/ — AVT, Inc. (OTC Markets: AVTC) (, a manufacturer of high performance automated retailing systems announced that they now offer entrepreneurs three distinct pathways to owning their own vending or automated retailing business.

The field of Automated Retailing (AR) has grown rapidly in recent years due to technological advances in the industry, and the affordability of starting a new AR business. Here are some key reasons why the industry is flourishing and why entrepreneurs are flocking to AR opportunities:

  1. Product Selection: Automated Retailing can provide consumers with a virtually limitless array of products in a convenient manner, without the need of a salesperson or waiting at a checkout line. The interesting products now available through automated retailing include: sunglasses, swimsuits, gourmet coffee, protein shakes, salads and healthy foods, clothing, electronics, iPods, digital cameras, cosmetics, and more. Automated Retailing can also provide services such as propane tank exchange, carpet cleaning rentals, and amazing new systems that clean and sanitize eyewear and jewelry. The bottom line: If there is something you want to sell, there is a machine that can automate the process.
  2. Ease of Management: New automated retailing systems provide wireless control and reporting, so entrepreneurs can monitor their systems from across town or across the country. Sales reports, inventory levels, and even demographic information can be downloaded in real time.
  3. Cost of Entry: One of the most compelling reasons that entrepreneurs are attracted to Automated Retailing is the low cost of ownership and ease of entry into the market. There are few other opportunities that offer such a turnkey system with a small investment. And while every AR opportunity is different, many have the potential to provide significant returns on investment.

AVT specializes in helping entrepreneurs start an Automated Retailing business. Some of the best-known and most highly acclaimed Automated Retailing businesses in the nation all got their start at AVT, including: HUMAN Healthy Vending, Medbox, Farmer’s Fridge, BurritoBox, plus the incredibly popular systems for fresh juice, caviar and cupcakes.

To find out more about how AVT provides entrepreneurs and business with opportunities to get into Automated Retailing, please visit the AVT website, at:, or call (877) 424-3663.

Media Inquiries:
Innovation Agency

To view the original version on PR Newswire, visit:

2 2237

There are very few people in the world that fall in the WW[BLANK]D category besides probably the big man himself. (Not Talking about Jesus Christ)

BUT investors around the world often find themselves asking ‘What Would Warren Buffett Do?’ just before or after making an investment.  Is it the right move for me? Will it make money? Should I take my profit or loss now?  All great questions but in the end I would say that it all comes back to the Oracle of Omaha himself.  So with that, What Would Warren Buffett Do in the case of an investment in marijuana stocks?



Big Buff’s Strategy 

To really grasp this to its fullest you really need to strip it down to the bare bones of Buffett’s investment fundamentals.  Warren Buffett is one of the richest men in the world. He built his fortune using a simple yet powerful investment strategy. His investments are long-term positions, accomplished by the purchase of strong companies that are trading well below their intrinsic value.  In a speech at Columbia Business School, later adapted into an essay, Buffett introduced what he called, “The Superinvestors of Graham-and-Doddsville.” (Benjamin Graham — whom Buffett studied under at Columbia — and Dave Dodd, with whom Graham wrote the book on security analysis…literally)


“The common intellectual theme of the investors from Graham-and-Doddsville is this: they search for discrepancies between the value of a business and the price of small pieces of that business in that market.”


In other words, Buffett doesn’t think about buying a stock; he thinks about buying a business. Buffett explains his thesis is based on the idea that the investors of Graham-and-Doddsville could care less about when they buy stocks, or be concerned about a stock’s beta or the “covariance in returns among securities.”


“These investors are businessmen buying pieces of businesses, not traders buying stocks.”


So when you think of it in a way of an acquisition based approach, the ideology of an investment versus the action of a trade takes a more profound meaning and with it, an entirely new sense of placing value on a stock and its underlying company.

Are Marijuana Stocks Warren’s ‘Pot’ of Gold?


Some would say that marijuana stocks could offer several key factors that Buffett looks for in the investments he makes.  For starters, Buffett relies on long-term trends and doesn’t necessarily concern himself with a bad quarter here or there. As long as business is growing and the product continues to “sell itself”, he is content (coming from a simplistic view of the WWWBD approach).  Banks, insurers, soft-drink makers, and railroads for example all benefit from a growing population that needs access to cash, ability to protect themselves from those unseen circumstances, and who can argue with Santa Claus pounding a glass bottle of Coke during the holidays?  When it comes to popular opinion, it would appear that as Americans, we’re all starting to look at weed the same way others look at Coca Cola…sure its loaded with sugar but “it’s not that bad.”


A recent Gallup poll conducted just prior to the midterm elections shows that “public support for legalizing the use of marijuana has clearly increased over the past decade.”  Furthermore “with a super-majority of younger Americans supportive — 64% of those aged 18 to 34, contrasted with 41% of those 55 and older — it seems inevitable that [legalization outside of more liberal states] will eventually change.”


Also in line with Buffett’s philosophy, price elasticity comes into play or rather the propensity for someone to buy a good regardless of price.  Marijuana could be seen as an inelastic commodity as so far it seems no matter what the price is, people are willing to buy.  Marijuana, in turn is something that at this point has a consistent demand unrelated to any other economic factors. Put another check mark in the “Buffett box”.


No Smoke, No Mirrors…Just Barriers


One thing that may not necessarily appeal to the Warren Buffett philosophy is the relatively easy road to getting involved in the marijuana industry.  Seemingly, it doesn’t appear that competition would be hot enough to have 4 or 5 major industry leaders to shake up the MJ space…just yet.


While rules and regulations definitely put up a wall when it comes to getting approved for a license (as a marijuana retailer), and patents would protect drugs developed by MJ companies focused on pharmaceutical applications, entering the marijuana industry isn’t all that hard…just look at the myriad companies already doing it in the penny stock market.


But here’s where the hook might be and it actually starts in the auto industry.  A recent article in Bloomberg Business Week cites that “In buying a chain of car dealerships, Buffett’s Berkshire Hathaway (BRK/B) sees plenty of moats (barriers to entry) and a clear path to consolidation.”


The industry is highly fragmented, for example the 10 largest U.S. dealers account for less than 10 percent of new vehicle sales (according to Morningstar). Buffett’s Berkshire Hathaway has plenty of opportunity to buy other dealers and help concentrate the industry This not only gives the company a cost advantage but by taking more of a “roll-up” approach, it gives pricing advantages as well.   Remember the reason why I said he might not like the industry?  Well it could be exactly why he should like it in the end.  In essence Buffett’s strategy would make him an industry leader that the market is currently lacking.


Could The Future Hold A Berkshire That Purports A Position in Pot?

Right now it’s probably not a likely avenue that this conglomerate would jump into.  We’re not even a year into the first legal recreational states reporting fiscal tax revenue nor is the country unanimously legalizing the drug.  It’s a very interesting scenario: You can go from Oregon to Washington with a joint and no one should seemingly care but the minute you cross into another state, you could potentially get put in jail for life!

WWWBD?  Probably stay far away from an investment where buyers of the product potentially face that kind of outcome.  So until the industry levels out, there is a clear track record of strong & consistent revenue, and until the industry is fully accepted in all states, I don’t foresee the ‘Oracle planning a portfolio strategy on marijuana stocks in the near future…but stranger things have happened so time will be the judge here in my opinion.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact